Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,875 | -5,835 | -4,638 | -5,136 | -2,872 |
| Depreciation Amortization | 1,131 | 729 | 476 | 676 | 7 |
| Accounts payable and accrued liabilities | 739 | 954 | 257 | 1,184 | 848 |
| Other Working Capital | 1,022 | 1,292 | 540 | 1,095 | 961 |
| Other Operating Activity | 3,356 | 1,214 | 2,425 | 1,026 | -898 |
| Operating Cash Flow | $-2,627 | $-1,646 | $-940 | $-1,154 | $-1,953 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -34 | -34 | -34 | -56 | 10 |
| Investing Cash Flow | $-34 | $-34 | $-34 | $-56 | $10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,823 | 1,733 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 1,200 | 1,413 | 366 |
| Debt Repayment | N/A | N/A | -143 | -47 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 1,327 |
| Other Financing Activity | -304 | -143 | 0 | 0 | 250 |
| Financing Cash Flow | $3,519 | $1,590 | $1,057 | $1,366 | $1,943 |
| Beginning Cash Position | 157 | 157 | 157 | 1 | 1 |
| End Cash Position | 1,105 | 67 | 240 | 157 | 1 |
| Net Cash Flow | $858 | $-90 | $83 | $156 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,627 | -1,646 | -940 | -1,154 | -1,953 |
| Free Cash Flow | -2,627 | -1,646 | -940 | -1,154 | -1,953 |